View in EDS

Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.

Saved in:
Bibliographic Details
Title: Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.
Authors: Strizki JM; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Gaspar JM; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Howe JA; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Hutchins B; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Mohri H; Aaron Diamond AIDS Research Center, Columbia University Medical Center , New York, New York, USA., Nair MS; Aaron Diamond AIDS Research Center, Columbia University Medical Center , New York, New York, USA., Kinek KC; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., McKenna P; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Goh SL; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Murgolo N; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jan 10; Vol. 68 (1), pp. e0095323. Date of Electronic Publication: 2023 Dec 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.00953-23